BUSINESS

• Medicon, Mucodyne among Drugs Subject to MHLW’s Ramp-Up Request
  October 20, 2023

• Oncology, Cell & Gene Therapies Key Priorities for Bayer Co.Labs: Global Head
  October 20, 2023

• Kyowa Kirin Set to Gain Tens of Billions of Yen in Sales from Orchard Acquisition
  October 20, 2023

• Takeda to Pay 130 Million Euro to Settle Tax Row over Shire-AbbVie Breakup Fee
  October 19, 2023

• Takeda’s 1st Cell Therapy Alofisel Misses Goal in Key PIII Study
  October 19, 2023

• Diazepam Nasal Spray Shows Efficacy in PIII Interim Analysis: Aculys
  October 19, 2023

• Fuji Pharma/M3’s Dysmenorrhea Drug Filed in Japan, 2024 Rollout Targeted
  October 19, 2023

• Herceptin Biosimilars Get Colorectal Cancer Nod: Celltrion, Nippon Kayaku
  October 19, 2023

• Daiichi Sankyo Ordered to Pay 8% Royalty to Seagen in ADC Patent Row
  October 19, 2023

• BMS Looks to Double Japan Biz in Next 10 Years with Partnership as a Pillar
  October 19, 2023

• Broader Use of Blood Biomarkers Key to Maximizing Leqembi’s Value: Eisai Exec
  October 18, 2023

• IBM Leads Development of Integrated Drug Supply Database for Wholesaler Reps, Pharmacists
  October 18, 2023

• Guardant Liquid Biopsy Test Approved as CDx for Targeted Colorectal Cancer Drugs
  October 17, 2023

• Telomelysin-Radiation Combo Hits Mark in PII Esophageal Cancer Study: Oncolys
  October 17, 2023

• Meiji/KM’s XBB.1.5-Tailored COVID Jab to Enter Pediatric PIII Study
  October 17, 2023

• EU Panel Backs Astellas’ Hot Flash Drug
  October 17, 2023

• Oral Flu Drug Prescriptions 17 Times Higher than Pre-COVID: September Survey
  October 16, 2023

• Japan Pharma Market to Contract after 2027 on Biosimilar Influx: Fuji Keizai
  October 13, 2023

• Shonan iPark Looks to Woo Korean Firms by Partnering with Govt: Chief
  October 13, 2023

• Viatris to Discontinue 28 APIs/48 Products for Supply, Productivity Reasons
  October 12, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 117
• 118
• 119
• 120
• 121
• 122
• 123
• 124
• 125
• …
• Next ›
• 最終 »